Irene Schmitt - Midatech Pharma Insider

Midatech Pharma Plc -- USA Stock  

USD 1.48  0.0361  2.5%

Member of the Supervisory Board

Ms. Irene Schmitt was Member of the Supervisory Board of Muenchener Tierpark Hellabrunn AG since July 24 2008. In addition she is active as Member of the City Council of the city of Muenchen.
  Executive Since 2008      
44 1235 841 575  http://midatechgroup.com

Management Efficiency

The company has Return on Asset of (23.16) % which means that on every $100 spent on asset it lost $23.16. This is way below average. In the same way, it shows return on shareholders equity (ROE) of (54.14) % meaning that it generated no profit with money invested by stockholders.
The company has 2.34 M in debt with debt to equity (D/E) ratio of 4.8 . This implies that the company may be unable to create cash to meet all of its financial commitments. Midatech Pharma Plc has Current Ratio of 1.59 which is typical for the industry and considered as normal.

Similar Executives

Found 14 records

EXECUTIVE Since

David AndersonVBI Vaccines Inc
2015
Shayla ForsterVBI Vaccines Inc
2015
Samuel WadsworthDimension Therapeutics Inc
2013
Eric CrombezDimension Therapeutics Inc
2014
Mary ThistleDimension Therapeutics Inc
2017
Sam WadsworthDimension Therapeutics Inc
N/A
Ayelet HornVascular Biogenics Ltd
2007
Ross TuboVericel Corporation
2014
Tien MDNantKwest Inc
N/A
Rishi GuptaDimension Therapeutics Inc
2015
Eric MDDimension Therapeutics Inc
N/A
Jacob GeorgeVascular Biogenics Ltd
2000
David ReckerVericel Corporation
2014
FRCPC MDDel Mar Pharmaceuticals Inc
N/A

Entity Summary

Midatech Pharma PLC, a specialty pharmaceutical company, focuses on the development and commercialization of target therapies for various diseases with unmet needs. Midatech Pharma Plc (MTP) is traded on Nasdaq Capital Markets in USA. It is located in UNITED KINGDOM and employs 100 people. Midatech Pharma is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Idea Analyzer Now
   

Idea Analyzer

Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Hide  View All  Next  Launch Idea Analyzer
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Midatech Pharma Plc to your portfolio

Top Management

Midatech Pharma Plc Leadership Team
Craig Cook, COO, MBA
Evelyne Menges, Executive
Tim Sparey, Executive, Ph.D
Paul Protopapas, Director
Beatrix Burkhardt, Executive
Andreas Knieriem, Executive
Irene Schmitt, Executive
Reinhard Zenau, Executive
MBA Palmer, Executive
Rolf Stahel, Chairman
Simon Turton, Director
Nicholas RobbinsCherry, Director, MBA
Frank Mueller, Executive
John Johnston, Director
Michele Luzi, Director, MBA
Harald Stroetgen, Chairman
James Phillips, CEO, MBA
Daniel Palmer, Executive, MBA
Simon Vries, Director, MBA
Justin Barry, Executive
Beatrix Koehler, Executive
Christine Strobl, Executive
Florian Vogel, Executive

Stock Performance

Midatech Pharma Performance Indicators